Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
Confirm Medicare Part B active coverage for the date of service
In the STEP-1 trial of 1,961 adults (Wilding and colleagues, Once-Weekly Semaglutide in Adults with Overweight or Obesity, New England Journal of Medicine, 2021), participants on semaglutide 2.4 mg lost an average of 14.9 percent of their body weight at 68 weeks, compared to 2.4 percent on placebo
Quantity: 10 ampoules
03 Receive Injection The injection is administered in-office according to current Eternal MedSpa protocol and product availability
US$ 24.45
US$ 24.91
US$ 25.34
US$ 27.57
US$ 24.15
US$ 21.68
